MA25753A1 - Sel de thiazol idinedione pour le traitement du mellius du diabete - Google Patents

Sel de thiazol idinedione pour le traitement du mellius du diabete

Info

Publication number
MA25753A1
MA25753A1 MA26933A MA26933A MA25753A1 MA 25753 A1 MA25753 A1 MA 25753A1 MA 26933 A MA26933 A MA 26933A MA 26933 A MA26933 A MA 26933A MA 25753 A1 MA25753 A1 MA 25753A1
Authority
MA
Morocco
Prior art keywords
mellius
diabetes
salt
treatment
idinedione
Prior art date
Application number
MA26933A
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA25753A1 publication Critical patent/MA25753A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
MA26933A 2000-06-08 2002-12-04 Sel de thiazol idinedione pour le traitement du mellius du diabete MA25753A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
MA25753A1 true MA25753A1 (fr) 2003-04-01

Family

ID=9893257

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26933A MA25753A1 (fr) 2000-06-08 2002-12-04 Sel de thiazol idinedione pour le traitement du mellius du diabete

Country Status (23)

Country Link
EP (1) EP1296980A1 (fr)
JP (1) JP2003535862A (fr)
KR (1) KR20030007918A (fr)
CN (1) CN1443186A (fr)
AP (1) AP2002002673A0 (fr)
AU (1) AU2001264078A1 (fr)
BG (1) BG107357A (fr)
BR (1) BR0111536A (fr)
CA (1) CA2411065A1 (fr)
CZ (1) CZ20023966A3 (fr)
DZ (1) DZ3382A1 (fr)
EA (1) EA200300005A1 (fr)
GB (1) GB0014006D0 (fr)
HU (1) HUP0301137A3 (fr)
IL (1) IL153279A0 (fr)
MA (1) MA25753A1 (fr)
MX (1) MXPA02012100A (fr)
NO (1) NO20025883L (fr)
OA (1) OA12284A (fr)
PL (1) PL360592A1 (fr)
SK (1) SK17142002A3 (fr)
WO (1) WO2001094344A1 (fr)
ZA (1) ZA200209954B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US20080176905A1 (en) * 2007-01-22 2008-07-24 Santiago Ini Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
EP1956018A1 (fr) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Procédé de préparation d'un dérivé du benzimidazole
WO2010021745A2 (fr) * 2008-08-21 2010-02-25 Teva Pharmaceutical Industries Ltd. Formes polymorphes de bromhydrate de rosiglitazone et leurs procédés de préparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
EP1296980A1 (fr) 2003-04-02
WO2001094344A1 (fr) 2001-12-13
CN1443186A (zh) 2003-09-17
CA2411065A1 (fr) 2001-12-13
CZ20023966A3 (cs) 2003-04-16
NO20025883D0 (no) 2002-12-06
BG107357A (bg) 2003-08-29
AP2002002673A0 (en) 2002-12-31
NO20025883L (no) 2003-02-03
MXPA02012100A (es) 2003-04-25
BR0111536A (pt) 2003-07-01
AU2001264078A1 (en) 2001-12-17
DZ3382A1 (fr) 2001-12-13
EA200300005A1 (ru) 2003-04-24
JP2003535862A (ja) 2003-12-02
SK17142002A3 (sk) 2003-10-07
OA12284A (en) 2003-11-10
HUP0301137A2 (hu) 2003-08-28
ZA200209954B (en) 2003-10-10
KR20030007918A (ko) 2003-01-23
HUP0301137A3 (en) 2005-04-28
GB0014006D0 (en) 2000-08-02
PL360592A1 (en) 2004-09-20
IL153279A0 (en) 2003-07-06

Similar Documents

Publication Publication Date Title
EP1831385A4 (fr) Enzymes pour le traitement d'amidon
EP1534074A4 (fr) Polytherapie pour le traitement de l'obesite
FR22C1033I1 (fr) Utilisation de dihydroimidazolones pour le traitement des chiens
ATE344253T1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
MA25823A1 (fr) Compositions pour le traitement de l'eau.
FR12C0077I2 (fr) Composition pour le traitement des condylomes génitaux
CH1143977H1 (fr) 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite
MA26992A1 (fr) Derives de phenethanolamine pour le traitement des maladies respiratoires
EP1536804A4 (fr) Ester 3'-l-valine de ?-d-2'-c-methyl-ribofuranosyl cytidine pour le traitement d'infections par des flaviviridae
DZ2936A1 (fr) Composition nouvelle à libération modifiée pour letraitement du diabète.
FR13C0029I1 (fr) Compositions pour le traitement de troubles gastro-intestinaux
MA26951A1 (fr) Derives de pyrazole pour le traitement de maladies virales
MA25847A1 (fr) Composition pour le traitement du dysfonctionnement endothelial.
EP1807396A4 (fr) Composes de 2-aminopyridine utiles comme inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer
DE60239220D1 (de) ClC-2-KANALÖFFNER ZUR BEHANDLUNG VON MAGEN- ODER DARM-ULCUS
EP1664011A4 (fr) Compositions ophtalmiques pour le traitement de l'hypertension oculaire
EP1359885A4 (fr) Inhibiteurs de nos pour le traitement des rides
EP1581243A4 (fr) Lactoferrine orale pour le traitement des sepsies
EP1750513A4 (fr) Utilisation de ligands gpcr54 pour le traitement de l'infertilite
FR2786390B1 (fr) Cotyle de correction pour emploi dans le traitement de pathologies de la hanche
FR2835851B1 (fr) Composition pour le traitement d'alliages de magnesium
EP1448193A4 (fr) Composes therapeutiques pour le traitement d'etats dyslipidemiques
FR2800614B1 (fr) Composition pour le traitement des infections des voies respiratoires
MA25852A1 (fr) Methode pour le traitement de l'inflammation.
EP1572129A4 (fr) Derives d'amidine pour le traitement des amyloses